Magnet Recognized 🌟 UPMC Eases Nursing Burden.
See Study
→
877-349-4582
Request A Demo
Search
Solutions
EndoTool Glucose Management System
EndoTool IV
EndoTool SubQ
Interoperability
Analytics
Professional Services
Why it Matters
Evidence
About
Company Overview
Leadership Team
Clinical Advisory Board
Newsroom
Partnerships
Careers
Resources
Blog
Contact
877-349-4582
Request A Demo
877-349-4582
Request A Demo
Blog
EndoTool
,
Glycemic Management
,
Hypothermia
/
Effective Glucose Management in Therapeutic Hypothermia Can Save Patient Neurological Function
Inducing mild hypothermia in some patients with cardiac arrest and other traumatic events has proven to significantly improve their long-term neurological function. Many experts feel that this is one of the most important advancements in the history of the science of resuscitation. According to Dr. Jonathan Adler, writing in Medscape, patients who have been shown to benefit from induced hypothermia...
EndoTool
Glycemic Management
Hypothermia
EndoTool
,
Renal Failure
,
Residual Insulin
/
Effectively Managing Blood Glucose in Patients With Renal Failure
Kidneys can be injured by a number of reasons. In the United States alone, more than 26 million people are estimated to have chronic kidney disease (CKD), although most don’t know it because early signs are often missed. “While diabetes is the leading cause of kidney failure that does not mean that everyone with diabetes will develop CKD severe enough...
EndoTool
Renal Failure
Residual Insulin
EndoTool
,
Hypoglycemia
,
Personalized Dosing
/
How EndoTool is Both Predictive and Prescriptive
Recently, there have been product announcements from companies in the glucose management space promoting new tools to “predict” hypoglycemia. There is a big difference between products that market hypoglycemia’s predictive ability and the EndoTool technology. EndoTool not only predicts changes in glucose levels, it also takes the next step in terms of treatment by adjusting insulin dosing recommendations for every...
EndoTool
Hypoglycemia
Personalized Dosing
EndoTool
,
SubQ Insulin Dosing
/
EndoTool SubQ: What You Should Know
Monarch Medical Technologies EndoTool SubQ provides clinical decision support for any situation where subcutaneous insulin is administered to all patient types, including pediatrics. This proprietary technology models, predicts and adjusts to each patient’s unique physiology and individual response to insulin. EndoTool will always recommend the safest, most effective patient-specific dose, beginning with the correct total daily dose and following with...
EndoTool
SubQ Insulin Dosing
EndoTool
,
IV Insulin Dosing
/
Seven-Year Study Suggests EndoTool is the Future of Inpatient Medicine
Advances in computer technology have brought about an ever-expanding list of tasks which had previously required the manual ‘human touch,’ and now are programmed to automatically occur. The high profile examples of this phenomenon are self-driving cars, thermostats that adjust themselves based on the time of day, and the amazing interconnectivity of the “Internet of Things.” Computer-guided systems can also...
EndoTool
IV Insulin Dosing
ADA
,
EndoTool
,
Guidelines and Standards
/
Inpatient Glycemic Control Through the Eyes of AACE and ADA: Part 3
In part 1 and part 2 of this series, we provided answers to questions regarding the safety and improvement of inpatient glycemic control, as well as the recommended glycemic targets and how to achieve them. Today, we will explain the cost effectiveness of treatment, and the optimal strategies for the transition to outpatient care. Improving the inpatient glycemic control protocol...
ADA
EndoTool
Guidelines and Standards
EndoTool
,
IV Insulin Dosing
/
EndoTool Customers Continue to Show Big Results
Vidant Medical Center publicizes seven-year outcome data from Monarch Medical Technologies EndoTool at American Diabetes Association 76th Scientific Sessions. Vidant Medical Center, the flagship hospital for Vidant Health in Greenville, NC, is presenting their poster reflecting the improvement in quality of care with patients being treated on EndoTool Glucose Management System. The poster, “Use of a Computer-Guided Glucose Management System...
EndoTool
IV Insulin Dosing
EndoTool
,
IV Insulin Dosing
,
Residual Insulin
/
Monarch Announces Groundbreaking EREI Technology
This past Wednesday, the team at Monarch Medical Technologies announced ground-breaking EREI technology for any hospital scenario where intravenous insulin is administered. Dr. Patrick Burgess, founder and inventor of EndoTool, described the technology as having the potential to nearly eliminate severe hypoglycemia while removing the risk of human oversight. EREI refers to “estimated residual extracellular insulin” present in a patient’s...
EndoTool
IV Insulin Dosing
Residual Insulin
EndoTool
/
Top 10 Reasons to Use EndoTool
Here are the top 10 reasons to use EndoTool: 10 – Confidence in Outcomes EndoTool is the market leader for safe glucose management for hospitalized patients and is trusted by more than 180 hospitals in the United States. 9 – Simple Process Once a facility begins using EndoTool, nurses follow a simple three-step process for safe dose recommendations. The process...
EndoTool
Computerized Dosing
,
EndoTool
,
Glycemic Management
/
Inpatient Glucose Management: Part 3
Glucose Management Software This blog series has been used to educate our readers on inpatient glucose management. In part 1, we explored the risks and complications, and in part 2, we explored best practices recommended by the American Diabetes Association and The Joint Commission. In this post, we will come full circle with the benefits of inpatient glucose management software....
Computerized Dosing
EndoTool
Glycemic Management
EndoTool
,
Personalized Dosing
,
Residual Insulin
/
Estimated Residual Extracellular Insulin (EREI): What Is It?
Estimated residual extracellular insulin, or EREI, refers to residual insulin present in a patient’s body. Every patient receiving insulin therapy requires personalized treatment based on their individual makeup. In addition to this, each patient’s need for insulin is not only different, but, ever-changing based on activity level, meals consumed and stress. The amount of residual insulin present in a person’s...
EndoTool
Personalized Dosing
Residual Insulin
EndoTool
,
IV Insulin Dosing
/
Study Compares EndoTool to Paper Protocol in the ICU
Everything is more intense in the intensive care unit (ICU). Critically ill patients demand more frequent and detailed monitoring as well as timely and precise interventions to address their fragile state. These patients health can be impacted by a wide range of factors, including blood sugar. Statistics show that approximately 30-50% of ICU patients experience stress-induced hyperglycemia, which is typically...
EndoTool
IV Insulin Dosing
EndoTool
,
Transition IV to SubQ
/
Streamlining the Transition from IV to SubQ Insulin
Intravenous (IV) insulin infusion is a standard protocol for treating critically ill hospitalized patients with hyperglycemia. However, once glucose levels stabilize, patients may be transitioned to subcutaneous (SubQ) insulin injections. The transition from IV to SubQ dosing involves many variables and can be difficult to achieve without a few bumps along the way. While some hospitals follow standard transition protocols,...
EndoTool
Transition IV to SubQ
Computerized Dosing
,
Cost Savings
,
EndoTool
/
Hospital Demonstrates LOS and Cost Benefit from Glucose Management Software
A study at United Regional Health Care System (URHCS), a major 325-bed hospital in Wichita Falls, Texas, proves that safe and efficient glucose management not only improves the delivery of insulin therapy, but decreases overall length of stay and results in financial savings for the hospital. As part of its commitment to leverage advanced medical technology for the benefit of...
Computerized Dosing
Cost Savings
EndoTool
EndoTool
,
SubQ Insulin Dosing
/
Glucose Management Software Optimizes Subcutaneous Insulin Dosing for Hospitalized Patients With Diabetes
When patients with diabetes enter the hospital, they don’t check their diabetes at the door. Managing diabetes while delivering treatment for other conditions is an added challenge for hospitalized patients where the condition may be either ongoing or a temporary abnormality. While always important, appropriate glucose management is particularly a concern for patients undergoing medical treatment — critical or not...
EndoTool
SubQ Insulin Dosing
Prev
1
2
3
4
Next
Search
Submit
Clear
Tags
A1C
ADA
CMS
Computerized Dosing
Conferences
Continuous Glucose Monitoring
Cost Savings
COVID-19
Diabetes
DKA
EMR Integration
EndoTool
Gestational Diabetes
Glycemic Management
Glycemic Steering Committee
Guidelines and Standards
Heart Failure
Hyperglycemia
Hypoglycemia
Hypothermia
Insulin
IV Insulin Dosing
Nursing
Obstetrics
Patient Safety
Performance Improvement
Personalized Dosing
Pharmacy
Renal Failure
Residual Insulin
Society of Hospital Medicine
SubQ Insulin Dosing
Surgical Site Infection
The Joint Commission
Transition IV to SubQ
Trauma
Wearable Technology
Workflow
Search
Submit
Clear
Client Login
Search
Submit
Clear
Solutions
EndoTool Glucose Management System
EndoTool IV
EndoTool SubQ
Interoperability
Analytics
Professional Services
Why it Matters
Evidence
About
Company Overview
Leadership Team
Clinical Advisory Board
Newsroom
Partnerships
Careers
Resources
Blog
Contact
Case Study
Discover UPMC Central Pennsylvania's approach to a 92% reduction in hypoglycemia.
Download Case Study
Scroll Up